ProKidney Corp.

NASDAQ:PROK

Biotechnology

Healthcare
$1.04 +0.86%

+$0.02 today

Market cap
$349.70M
Beta
1.70
P/E (TTM)
-3.3
EPS (TTM)
-$0.53
52W Low $0.54High $7.13

Volume 1.80M

Average 0.96M

Returns on capital

ProKidney Corp. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

6.8%

avg -135.9%

ROIC

-53.9%

avg -152.0%

ROA

-20.6%

avg -109.5%

Analysis

ROE is currently the strongest return metric at 6.8% versus its period average of -135.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Bruce Culleton

Chief Executive Officer & DirectorUSD 1.18M57500.00K0.34%

Todd C. Girolamo

Chief Legal Officer & SecretaryUSD 725.1K610<0.01%

James Coulston

Chief Financial OfficerUSD 724.87K49600.00K0.40%

Darin J. Weber

Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access—58200.00K0.13%

Joseph Stavas

Senior Vice President of Interventional Procedures————

Gregory Madison

Chief Commercial Officer—59——

Kenneth Locke

Chief Technical Officer————

Carla Poulson

Chief People Officer————

Emily Butler

Senior Vice President of Biometric————

Richard Williams

Chief Information Officer————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 2, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

5

$751,209.41

Net Transaction Value

−$751,209.41

Net selling

Most Active

Pereira Brian JG

5 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 20, 26

Pereira Brian JG

Direct

Sell$38.4K
Aug 19, 26

Pereira Brian JG

Direct

Sell$39K
Aug 19, 26

Pereira Brian JG

Indirect

Sell$321.2K
Aug 18, 26

Pereira Brian JG

Direct

Sell$38.2K
Aug 18, 26

Pereira Brian JG

Indirect

Sell$314.5K

Summary

Insiders reported 0 buys worth $0.00 and 5 sells worth $751,209.41 over the last 12 months. That adds up to net selling of $751,209.41. Pereira Brian JG was the most active insider with 5 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
+207.7% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Forward estimates point to Revenue at +207.7% (5yr), giving you a quick read on expected growth from here.

Competitors

Who does ProKidney Corp. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about PROK's management, answered from reported figures.

Who manages PROK?

ProKidney Corp. (PROK) lists 10 active executives. The top listed executive is Darin J. Weber, Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access.

Are PROK insiders buying or selling?

Recent insider activity shows net buying of $145.62M.